Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort descending Journal
5-Fluorouracil-Related Cardiotoxicity; Findings from Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer Clinical Colorectal Cancer
A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model Statistical Methods in Medical Research
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer Journal of Clinical Oncology
A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) Journal of Clinical Oncology
A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials Nature Scientific Data
A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer F1000 Research
Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials The Breast
Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study World Journal of Gastrointestinal Oncology
Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer JAMA Network Open
Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. PLOS ONE
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab Cancer Immunology, Immunotherapy
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel European Urology
Can synthetic data be a proxy for real clinical trial data? A validation study BMJ Open
Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment Journal of Theoretical Biology

Pages